Report Detail
Global Docetaxel Market Growth 2019-2024
- RnM2996237 |
- 21 February, 2019 |
- Global |
- 133 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
The classification of Docetaxel includes 20 mg/ml, 40 mg/ml and 60 mg/ml. And the proportion of 20 mg/ml in 2017 is about 86% and the proportion is stable from 2013 to 2017.
Docetaxel is widely used For Breast Cancer, Prostate Cancer, Non-small Cell Lung Cancer and Cancer. The most proportion of Docetaxel used for Breast Cancer and the proportion in 2017 is 85%.
According to this study, over the next five years the Docetaxel market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Docetaxel business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Docetaxel market by product type, application, key manufacturers and key regions and countries.
This study considers the Docetaxel value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
20 mg/ml
40 mg/ml
60 mg/ml
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Breast Cancer
Prostate Cancer
Non-small Cell Lung Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Docetaxel consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Docetaxel market by identifying its various subsegments.
Focuses on the key global Docetaxel manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Docetaxel with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Docetaxel submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Docetaxel Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Docetaxel Consumption 2014-2024
- 2.1.2 Docetaxel Consumption CAGR by Region
- 2.2 Docetaxel Segment by Type
- 2.2.1 20 mg/ml
- 2.2.2 40 mg/ml
- 2.2.3 60 mg/ml
- 2.3 Docetaxel Consumption by Type
- 2.3.1 Global Docetaxel Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Docetaxel Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Docetaxel Sale Price by Type (2014-2019)
- 2.4 Docetaxel Segment by Application
- 2.4.1 Breast Cancer
- 2.4.2 Prostate Cancer
- 2.4.3 Non-small Cell Lung Cancer
- 2.4.4 Other
- 2.5 Docetaxel Consumption by Application
- 2.5.1 Global Docetaxel Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Docetaxel Value and Market Share by Application (2014-2019)
- 2.5.3 Global Docetaxel Sale Price by Application (2014-2019)
3 Global Docetaxel by Players
- 3.1 Global Docetaxel Sales Market Share by Players
- 3.1.1 Global Docetaxel Sales by Players (2017-2019)
- 3.1.2 Global Docetaxel Sales Market Share by Players (2017-2019)
- 3.2 Global Docetaxel Revenue Market Share by Players
- 3.2.1 Global Docetaxel Revenue by Players (2017-2019)
- 3.2.2 Global Docetaxel Revenue Market Share by Players (2017-2019)
- 3.3 Global Docetaxel Sale Price by Players
- 3.4 Global Docetaxel Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Docetaxel Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Docetaxel Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Docetaxel by Regions
- 4.1 Docetaxel by Regions
- 4.1.1 Global Docetaxel Consumption by Regions
- 4.1.2 Global Docetaxel Value by Regions
- 4.2 Americas Docetaxel Consumption Growth
- 4.3 APAC Docetaxel Consumption Growth
- 4.4 Europe Docetaxel Consumption Growth
- 4.5 Middle East & Africa Docetaxel Consumption Growth
5 Americas
- 5.1 Americas Docetaxel Consumption by Countries
- 5.1.1 Americas Docetaxel Consumption by Countries (2014-2019)
- 5.1.2 Americas Docetaxel Value by Countries (2014-2019)
- 5.2 Americas Docetaxel Consumption by Type
- 5.3 Americas Docetaxel Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Docetaxel Consumption by Countries
- 6.1.1 APAC Docetaxel Consumption by Countries (2014-2019)
- 6.1.2 APAC Docetaxel Value by Countries (2014-2019)
- 6.2 APAC Docetaxel Consumption by Type
- 6.3 APAC Docetaxel Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Docetaxel by Countries
- 7.1.1 Europe Docetaxel Consumption by Countries (2014-2019)
- 7.1.2 Europe Docetaxel Value by Countries (2014-2019)
- 7.2 Europe Docetaxel Consumption by Type
- 7.3 Europe Docetaxel Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Docetaxel by Countries
- 8.1.1 Middle East & Africa Docetaxel Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Docetaxel Value by Countries (2014-2019)
- 8.2 Middle East & Africa Docetaxel Consumption by Type
- 8.3 Middle East & Africa Docetaxel Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Docetaxel Distributors
- 10.3 Docetaxel Customer
11 Global Docetaxel Market Forecast
- 11.1 Global Docetaxel Consumption Forecast (2019-2024)
- 11.2 Global Docetaxel Forecast by Regions
- 11.2.1 Global Docetaxel Forecast by Regions (2019-2024)
- 11.2.2 Global Docetaxel Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Docetaxel Forecast by Type
- 11.8 Global Docetaxel Forecast by Application
12 Key Players Analysis
- 12.1 Hengrui Medicine
- 12.1.1 Company Details
- 12.1.2 Docetaxel Product Offered
- 12.1.3 Hengrui Medicine Docetaxel Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Hengrui Medicine News
- 12.2 Sanofi
- 12.2.1 Company Details
- 12.2.2 Docetaxel Product Offered
- 12.2.3 Sanofi Docetaxel Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Sanofi News
- 12.3 Qilu Pharma
- 12.3.1 Company Details
- 12.3.2 Docetaxel Product Offered
- 12.3.3 Qilu Pharma Docetaxel Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Qilu Pharma News
- 12.4 Shenzhen Main Luck Pharma
- 12.4.1 Company Details
- 12.4.2 Docetaxel Product Offered
- 12.4.3 Shenzhen Main Luck Pharma Docetaxel Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Shenzhen Main Luck Pharma News
- 12.5 Jiangsu Aosaikang Pharma
- 12.5.1 Company Details
- 12.5.2 Docetaxel Product Offered
- 12.5.3 Jiangsu Aosaikang Pharma Docetaxel Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Jiangsu Aosaikang Pharma News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Docetaxel . Industry analysis & Market Report on Docetaxel is a syndicated market report, published as Global Docetaxel Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Docetaxel market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
